Biotech Celsion Corporation Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4) July 19, 2022
Biotech Allena Pharmaceuticals Announces Completion of Enrollment of Cohorts A and B of ALLN-346 Phase 2a Study 202 in Patients with Gout and Stages 2 and 3 Chronic Kidney Disease July 19, 2022
Biotech AnPac Bio Approved Written Resolutions of a Majority of the Members Addressing the Removal of Directors and Officers, Re-designation of Officers, and Change of Members of the Committees July 18, 2022
Biotech Adial Pharmaceuticals to Announce Topline Results of ONWARD(TM) Phase 3 Trial for AD04 in Patients With Alcohol Use Disorder July 18, 2022
Biotech Acer Therapeutics Announces Resubmission of New Drug Application for ACER-001 for Treatment of UCDs July 18, 2022
Biotech Eiger Appoints Senior Human Resources and Organizational Executive Lisa Kelly-Croswell to Board of Directors July 18, 2022